|
|
||||||||
J Thorac Cardiovasc Surg 2008;135:603-609
© 2008 The American Association for Thoracic Surgery
Evolving Technology |
a Departments of Cardiac Surgery and Anesthesia, Children's Hospital Boston, Harvard Medical School, Boston, Mass
b Department of Pediatric Cardiology, Kardiozentrum, La Paz, Bolivia
c Department of Pediatric Cardiothoracic Surgery, Columbus Children's Hospital, Columbus, Ohio
d Department of Pediatric Cardiology, Grosshadern University Hospital, University of Munich, Munich, Germany
e Ultrasound Division, Philips Medical Systems, Andover, Mass
* Address for reprints: Emile A. Bacha, MD, Department of Cardiac Surgery, Children's Hospital Boston, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115 (Email: emile.bacha{at}cardio.chboston.org).
Objectives: Safe and effective device closure of ventricular septal defects remains a challenge. We have developed a transcardiac approach to close ventricular septal defects using a patch delivery and fixation system that can be secured under real-time three-dimensional echocardiographic guidance.
Methods: In Yorkshire pigs (n = 8) a coring device was introduced into the left ventricle through a purse-string suture placed on the left ventricular apex, and a muscular ventricular septal defect was created. The patch deployment device containing a 20-mm polyester patch was advanced toward the ventricular septal defect through another purse-string suture on the left ventricular apex, and the patch was deployed under real-time three-dimensional echocardiographic guidance. The anchor delivery device was then introduced into the left ventricle through the first purse-string suture. Nitinol anchors to attach the patch around the ventricular septal defect were deployed under real-time three-dimensional echocardiographic guidance. After patch attachment, residual shunts were sought by means of two-dimensional and three-dimensional color Doppler echocardiography. The heart was then excised, and the septum with the patch was inspected.
Results: A ventricular septal defect was created in the midventricular (n = 4), anterior (n = 2), and apical (n = 2) septum. The mean size was 9.8 mm (8.2–12.0 mm), as determined by means of two-dimensional color Doppler scanning. The ventricular septal defects were completely closed in 7 animals. In one a 2.4-mm residual shunt was identified. No anatomic structures were compromised.
Conclusions: Beating-heart perventricular muscular ventricular septal defect closure without cardiopulmonary bypass can be successfully achieved by using a catheter-based patch delivery and fixation system under real-time three-dimensional echocardiographic guidance. This approach might be a better alternative to cardiac surgery or transcatheter device closure.
Related Article
J. Thorac. Cardiovasc. Surg. 2008 135: 603-609.
This article has been cited by other articles:
![]() |
R. Kozlik-Feldmann, N. Lang, A. Lehner, M. Sigler, C. Schmitz, R. Sodian, F. Freudenthal, R. Dalla-Pozza, N. V. Vasilyev, P. J. del Nido, et al. Evaluation of a new hybrid technique for closure of muscular ventricular septal defects in a long-term setting. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 365 - 373. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |